| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C0013210> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C0013211> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C0015179> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C0018223> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C0022132> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C0041700> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C0162692> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C0162693> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C0162694> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C0162695> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C0162696> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C0524590> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C0524591> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C0524592> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C0600216> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C3658241> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C3658242> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C3658243> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C3713756> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C4279964> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C4505148> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C4505149> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C5387588> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C5391442> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C5416844> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C5433402> <https://research.tib.eu/covid-19/entity/35228506_HAS_TOPIC_C5435314>
?:authorAffiliation	[\'Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Parums_Dinah_V>
?:doi	10.12659/MSM.936523
?:doi	<https://research.tib.eu/covid-19/entity/10.12659/MSM.936523>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Editorial>
?:journal	Medical science monitor : international medical journal of experimental and clinical research
is ?:pmid of	<https://research.tib.eu/covid-19/entity/35228506>
?:pmid	<https://research.tib.eu/covid-19/entity/35228506>
?:pmid	35228506
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
?:title	Editorial: First Approval of the Protein-Based Adjuvanted Nuvaxovid (NVX-CoV2373) Novavax Vaccine for SARS-CoV-2 Could Increase Vaccine Uptake and Provide Immune Protection from Viral Variants.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2022

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/35228506>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/35228506>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all